Please login to the form below
outcomes
This page shows the latest outcomes news and features for those working in and with pharma, biotech and healthcare.
Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
EGFR-mutated NSCLC often develops resistance to EGFR-targeting drugs like Tagrisso over time, highlighting the need for new therapies designed to improve outcomes for patients whose options are otherwise limited.
Latest news
-
AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain
Results showing EGFR-inhibitor improves outcomes in adjuvant setting released at ESMO 2020 virtual congress.
-
Lilly’s Olumiant combined with Gilead’s remdesivir hits the mark in COVID-19
The combination treatment also met the secondary endpoint of comparing patient outcomes at day 15, using an ordinal eight-point scale ranging from fully recovered to death. ... This data allows us to better understand baricitinib’s role in potentially
-
Roche’s Ocrevus boasts positive long-term data in MS
Ocrevus. Patients treated with Ocrevus also experienced an improvement in the majority of their symptoms, as measured by the SymptoMScreen outcome tool.
-
Positive COPD data for Synairgen's SNG001 supports COVID-19 programme
Aside from improving outcomes on these measures, SNG001 was also well-tolerated during the treatment period in a high-risk study population, with the mean age of participants being 66 years
-
Standard steroid improves recovery of critically-ill COVID-19 patients
The trial found that using the fixed dose of hydrocortisone caused a 93% improvement in patient outcomes, which included an improved chance of survival and reduced need for organ support. ... The studies show that we now have more than one choice of
More from news
Approximately 14 fully matching, plus 1,789 partially matching documents found.
Latest Intelligence
-
BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches
Amgen Oncology, one of the leading developers of innovative therapies for novel targets in difficult-to-treat cancers, is working to bring new hope for transforming clinical outcomes for patients with
-
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Moreover, 80% of respondents said that the crisis had materially affected their daily work lives, driving a wide variety of experiences, challenges and outcomes.
-
Exploiting the value of data in pharma
outcome. Conversely, a narrow focus on line-of-business hypotheses may be missing cross- organisational value in the massive data sets held which could be exploited more widely to accelerate innovation ... and making predictions for future outcomes and
-
What’s next? How behavioural science can support pharma’s future
A number of behavioural biases inhibited this adoption. One example is ‘satisficing’, the tendency to settle for ‘good enough’ rather than the best possible outcome. ... will result in a positive outcome for their brand.
-
Persuasive technology: designing behaviour change initiatives for digital
Strategies to support individual knowledge and treatment decisions for better patient outcomes are no longer the reserve of pharma reps and on-site scientific meetings. ... lives. Combined with EPG Health’s customer toolset to ‘reach, engage and
More from intelligence
Approximately 10 fully matching, plus 482 partially matching documents found.
Latest appointments
-
New faces at Synergy Vision, Makara Health and JPA Health
I’m passionate about delivering projects that challenge the status quo and improve patient outcomes, so this is an incredibly exciting time to be at the forefront of medical communications with
-
New faces at Lucid Group and ZPB Associates
of our end goal, which is improving patient outcomes,” said Goodwin.
-
F-star hires ex-BMS immuno-oncology leader
pipeline. As we saw at the recent ASCO meeting, bispecific antibodies are leading a paradigm shift in cancer care and the potential to improve the outcome for cancer patients has never
-
New faces at Lucid, 90Ten and Page & Page
I’m looking forward to being part of such a pioneering business where everything really is about improving patient outcomes.”.
-
Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
outcomes and value ‘beyond the product'.
More from appointments
Approximately 0 fully matching, plus 64 partially matching documents found.
Latest from PMHub
-
Crisis? No problem!
patient reported outcomes) where you are a clear leader. By bringing the story back to your own strong territory, you can try to make any resulting coverage more balanced.
-
Improve clinical trials through patient journey mapping
ultimately improve clinical study outcomes.
-
OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020
patient outcomes.
-
Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond
Dedicated to helping clients connect consumers, professionals, and brands with information services, and influences to drive new relationships and better outcomes.
-
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
To learn more about our client’s approach and the outcomes of this project, read the full customer story here: . Address:. Impetus Digital. WaterPark Place. 20 Bay Street, 11th Floor. Toronto.
More from PMHub
Approximately 9 fully matching, plus 526 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- New study identifies drugs that are safe to use in COVID-19 treatment
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- Moderna inks R&D agreements with Vertex and Chiesi
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Using Artificial Intelligence to Transform Pharma
- Session 4: Systems Innovation Insight and Thinking
- Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- Keytruda doubles five-year survival rate in NSCLC
- EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
